US 10457725
Methods of treating skin cancer by administering a PD-1 inhibitor
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10457725 (Methods of treating skin cancer by administering a PD-1 inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K2300/00